Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.

De Ravin SS, Wu X, Moir S, Anaya-O'Brien S, Kwatemaa N, Littel P, Theobald N, Choi U, Su L, Marquesen M, Hilligoss D, Lee J, Buckner CM, Zarember KA, O'Connor G, McVicar D, Kuhns D, Throm RE, Zhou S, Notarangelo LD, Hanson IC, Cowan MJ, Kang E, Hadigan C, Meagher M, Gray JT, Sorrentino BP, Malech HL, Kardava L.

Sci Transl Med. 2016 Apr 20;8(335):335ra57. doi: 10.1126/scitranslmed.aad8856. Erratum in: Sci Transl Med. 2016 Jun 1;8(341):341er5.

2.

Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

Tursiella ML, Bowman ER, Wanzeck KC, Throm RE, Liao J, Zhu J, Sample CE.

PLoS Pathog. 2014 Oct 2;10(10):e1004415. doi: 10.1371/journal.ppat.1004415. eCollection 2014 Oct.

3.

Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity.

Chan WK, Suwannasaen D, Throm RE, Li Y, Eldridge PW, Houston J, Gray JT, Pui CH, Leung W.

Leukemia. 2015 Feb;29(2):387-95. doi: 10.1038/leu.2014.174. Epub 2014 Jun 3.

4.

False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.

De Ravin SS, Gray JT, Throm RE, Spindler J, Kearney M, Wu X, Coffin JM, Hughes SH, Malderelli F, Sorrentino BP, Malech HL.

Mol Ther. 2014 Feb;22(2):244-245. doi: 10.1038/mt.2013.296. No abstract available.

5.

Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection.

Throm RE, Ouma AA, Zhou S, Chandrasekaran A, Lockey T, Greene M, De Ravin SS, Moayeri M, Malech HL, Sorrentino BP, Gray JT.

Blood. 2009 May 21;113(21):5104-10. doi: 10.1182/blood-2008-11-191049. Epub 2009 Mar 13.

6.

Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi.

Leduc I, White CD, Nepluev I, Throm RE, Spinola SM, Elkins C.

Infect Immun. 2008 Apr;76(4):1608-16. doi: 10.1128/IAI.00994-07. Epub 2008 Jan 22.

7.

DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.

Bong CT, Throm RE, Fortney KR, Katz BP, Hood AF, Elkins C, Spinola SM.

Infect Immun. 2001 Mar;69(3):1488-91.

8.
9.

Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.

Throm RE, Al-Tawfiq JA, Fortney KR, Katz BP, Hood AF, Slaughter CA, Hansen EJ, Spinola SM.

Infect Immun. 2000 May;68(5):2602-7.

Supplemental Content

Loading ...
Support Center